Antagonism of androgen receptor signaling by aloe-emodin

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Androgen receptor (AR) signaling is a critical factor in prostate cancer development and recurrence.
• Targeting AR signaling is a primary strategy for prostate cancer treatment.

Purpose of the Study:

• To identify novel antagonists of androgen receptor (AR) signaling.
• To investigate the potential of aloe-emodin as an AR antagonist for prostate cancer therapy.

Main Methods:

• Cell growth inhibition and apoptosis assays using LNCaP cells.
• Western blot and quantitative real-time PCR to analyze AR protein levels and gene expression.
• Immunofluorescence to track AR nuclear translocation.
• Molecular docking and dynamics simulations to study aloe-emodin-AR interactions.

Main Results:

• Aloe-emodin significantly inhibited LNCaP cell growth by inducing apoptosis.
• Aloe-emodin promoted AR proteasomal degradation, reducing AR protein levels.
• Aloe-emodin suppressed the transcription of AR target genes (PSA, KLK2, TMPRSS2).
• Aloe-emodin prevented AR nuclear translocation by forming stable complexes with AR, likely affecting ligand binding.

Conclusions:

• Aloe-emodin acts as a novel AR antagonist, inhibiting AR signaling pathways crucial for prostate cancer.
• Aloe-emodin demonstrates potential as a therapeutic agent for prostate cancer prevention or as a complementary treatment.